Leen H. Kawas, Ph.D. - Publications

2011 Pharmaceutical Sciences Washington State University, Pullman, WA, United States 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gordesli-Duatepe FP, Park BJ, Kawas LH, Abu-Lail NI. Atomic Force Microscopy Investigation of the Contributions of Cell-Wall Biomacromolecules to Their Adherence and Mechanics. The Journal of Physical Chemistry. B. PMID 32544332 DOI: 10.1021/acs.jpcb.0c04025  0.44
2019 Vanderwerff BR, Church KJ, Kawas LH, Harding JW. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma. Cytokine. 123: 154762. PMID 31254927 DOI: 10.1016/j.cyto.2019.154762  0.92
2015 Uribe PM, Kawas LH, Harding JW, Coffin AB. Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure. Frontiers in Cellular Neuroscience. 9: 3. PMID 25674052 DOI: 10.3389/fncel.2015.00003  0.92
2015 Wright JW, Kawas LH, Harding JW. The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases. Progress in Neurobiology. 125: 26-46. PMID 25455861 DOI: 10.1016/j.pneurobio.2014.11.004  0.8
2014 Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, Harding JW. The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. The Journal of Pharmacology and Experimental Therapeutics. 351: 390-402. PMID 25187433 DOI: 10.1124/jpet.114.218735  0.8
2013 Wright JW, Kawas LH, Harding JW. A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases. Frontiers in Endocrinology. 4: 158. PMID 24298267 DOI: 10.3389/fendo.2013.00158  0.92
2013 McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, Harding JW. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. The Journal of Pharmacology and Experimental Therapeutics. 344: 141-54. PMID 23055539 DOI: 10.1124/jpet.112.199497  0.8
2013 Kawas LH, Benoist CC, Harding JW, Wayman GA, Abu-Lail NI. Nanoscale mapping of the Met receptor on hippocampal neurons by AFM and confocal microscopy. Nanomedicine : Nanotechnology, Biology, and Medicine. 9: 428-38. PMID 22960190 DOI: 10.1016/j.nano.2012.08.008  0.8
2012 Wright JW, Wilson WL, Wakeling V, Boydstun AS, Jensen A, Kawas L, Harding JW. The Hepatocyte Growth Factor/c-Met Antagonist, Divalinal-Angiotensin IV, Blocks the Acquisition of Methamphetamine Dependent Conditioned Place Preference in Rats. Brain Sciences. 2: 298-318. PMID 24961196 DOI: 10.3390/brainsci2030298  0.92
2012 Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, Harding JW. Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers. The Journal of Pharmacology and Experimental Therapeutics. 340: 539-48. PMID 22129598 DOI: 10.1124/jpet.111.188136  0.8
2011 Kawas LH, Yamamoto BJ, Wright JW, Harding JW. Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity. The Journal of Pharmacology and Experimental Therapeutics. 339: 509-18. PMID 21859930 DOI: 10.1124/jpet.111.185694  0.8
Show low-probability matches.